250 related articles for article (PubMed ID: 12537979)
21. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
22. Anticancer effects of fenretinide in human medulloblastoma.
Damodar Reddy C; Guttapalli A; Adamson PC; Vemuri MC; O'Rourke D; Sutton LN; Phillips PC
Cancer Lett; 2006 Jan; 231(2):262-9. PubMed ID: 16399227
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
Holmes WF; Soprano DR; Soprano KJ
J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
[TBL] [Abstract][Full Text] [Related]
24. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
Shen JC; Wang TT; Chang S; Hursting SD
Mol Carcinog; 1999 Mar; 24(3):160-8. PubMed ID: 10204800
[TBL] [Abstract][Full Text] [Related]
26. The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines.
Merritt G; Aliprandis ET; Prada F; Rigas B; Kashfi K
Cancer Lett; 2001 Mar; 164(1):15-23. PubMed ID: 11166911
[TBL] [Abstract][Full Text] [Related]
27. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
28. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
[TBL] [Abstract][Full Text] [Related]
29. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
[TBL] [Abstract][Full Text] [Related]
30. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
31. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
Yang X; Hao Y; Ding Z; Pater A
Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
[TBL] [Abstract][Full Text] [Related]
33. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
[TBL] [Abstract][Full Text] [Related]
34. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells.
Wang TT; Phang JM
Cancer Lett; 1996 Oct; 107(1):65-71. PubMed ID: 8913268
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment.
Bruno S; Tenca C; Saverino D; Ciccone E; Grossi CE
Carcinogenesis; 2002 Mar; 23(3):447-56. PubMed ID: 11895859
[TBL] [Abstract][Full Text] [Related]
37. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
38. N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention.
Sharp RM; Bello-DeOcampo D; Quader ST; Webber MM
Mutat Res; 2001 Sep; 496(1-2):163-70. PubMed ID: 11551492
[TBL] [Abstract][Full Text] [Related]
39. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]